Product Validation by Cancer Patients - Oncoflavour
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Liking of 5 different oral nutritional supplements with adapted flavors
研究概览
简要总结
Oral nutritional supplements (ONS) are often prescribed for malnourished patients to help improve nutritional status. Commonly in cancer patients taste and smell alterations and side effects of treatment can affect the palatability and compliance to ONS. A variety of flavours and styles are available of ONS however research of the palatability of these in cancer patients is limited. This study aims to evaluate specific flavours created based on the taste changes occuring during treatment.
We aim to evaluate the patient liking and evaluation of 5 flavors in 3 different types of flavour-sensations:
- Warming/spicy sensation: to trigger the senses and bring new sensations
- Cooling/fresh sensation: to have a fresh mouthfeel and lighter base perception
- Neutral: to avoid that patients experience additional flavour and let them the opportunity to mix it with other food
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •> 18 years old
- •Ability to complete and comprehend questionnaires provided
- •Undergoing systemic cancer treatment (chemotherapy or concurrent chemoradiotherapy, radiotherapy, targeted therapy or immunotherapy)
排除标准
- •Uncertainty about the willingness or ability of the patient to comply with the protocol requirements (no impairment and no cognitive impairments)
- •Coexisting-morbidities affecting taste or smell function
- •Lactose Intolerance or Galactosaemia
- •Dysphagia
- •Diabetics
- •Food allergies/intolerances to ingredients present in the product
- •No rejection of lemon, red fruits, exotic fruit, yellow fruit flavours.
结局指标
主要结局
Liking of 5 different oral nutritional supplements with adapted flavors
时间窗: 20 minutes
To evaluate patient liking and perception about 5 new flavors on a 10-point scale via a sip test
次要结局
未报告次要终点